Abbott Laboratories buy Piper Sandler
Start price
17.10.24
/
50%
€109.48
Target price
17.10.25
€122.61
Performance (%)
4.34%
Price
02.07.25
€113.66
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler shows slight gains of 4.34%. Dividends of €0.57 are taken into consideration when calculating the performance. This prediction currently runs until 17.10.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.596% | -3.596% |
| iShares Core DAX® | 1.263% | -1.123% |
| iShares Nasdaq 100 | 0.531% | 2.176% |
| iShares Nikkei 225® | 1.532% | 1.686% |
| iShares S&P 500 | 0.904% | 1.784% |
Comments by Piper_Sandler for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Piper Sandler from $131.00 to $133.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Piper_Sandler for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€116.00
17.04.25
17.04.25
€127.60
17.04.26
17.04.26
-2.02%
02.07.25
02.07.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.70
19.09.24
19.09.24
€117.72
19.09.25
19.09.25
10.64%
02.07.25
02.07.25